
Keywords: MDD; major depressive disorder; BD; bipolar disorder; ASA; acetyl-salicylic acid; WHO; World Health Organization; TCAs; tricyclic antidepressants; MAOIs; monoamine oxidase inhibitors; SSRIs; selective serotonin reuptake inhibitors; PAMPs; pathogen associa